Meeting
2016 ASCO Annual Meeting
Assessment of tumor mutation burden from >60,000 clinical cancer patients using comprehensive genomic profiling.
Authors
Garrett Michael Frampton
Foundation Medicine, Inc., Cambridge, MA
Garrett Michael Frampton , David Fabrizio , Zachary Rockow Chalmers , Jeffrey S. Ross , Douglas Buckner Johnson , Christine Marie Lovly , Jeffrey Alan Sosman , Vincent A. Miller , Phil Stephens
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Citation
J Clin Oncol 34, 2016 (suppl; abstr 11558)
DOI
10.1200/JCO.2016.34.15_suppl.11558
Abstract #
11558
Poster Bd #
255
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Tumor mutational burden (TMB) in real-world patients with pancreatic ductal adenocarcinoma (PDAC): Differences in genomic alterations (GA) and predictive value for immune checkpoint inhibitor (ICI) effectiveness.
First Author: Amit Mahipal
Poster
2023 ASCO Annual Meeting
A phase II study of olaparib (AZD2281) in patients (Pts) with metastatic/advanced urothelial carcinoma and other genitourinary (GU) tumors with DNA-repair defects.
First Author: Elias Chandran
Poster
2020 Genitourinary Cancers Symposium
Genomic profiling of prostate cancer at a diverse academic center.
First Author: Robert Lopez
Poster
2018 Gastrointestinal Cancers Symposium
Variations in DNA repair genomic alterations and tumor mutation burden in biliary tract cancer (BTC) subtypes.
First Author: Reham Abdel-Wahab